Biocryst Pharmaceuticals Cash Flow Statement (2010-2015) | BCRX

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015
Operating Activities
Net Income -10.86M-10.20M-11.69M-13.87M-12.12M-6.09M-11.28M-6.46M-13.29M-8.10M-7.55M-8.61M-12.82M-12.81M-16.43M-15.63M4.15M-14.27M
Share-based Compensation 1.43M1.31M1.47M1.26M1.14M0.90M1.04M1.13M1.17M0.82M1.60M0.92M0.96M0.89M1.61M3.52M1.42M3.63M2.26M3.67M1.84M1.93M
Gains from Investment Securities 7.86M8.70M8.66M8.07M9.12M8.99M8.54M8.37M8.35M9.61M10.25M9.78M9.79M
Non-cash Items 0.19M0.35M0.56M0.83M33.70M
Cash from Operations -9.23M-5.82M-14.33M-3.47M-10.47M-3.98M-12.25M-6.34M-11.78M-7.03M-11.20M-2.90M-7.92M-4.51M-8.96M-7.10M-8.60M-13.89M-3.73M18.10M-12.66M-14.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.19M0.11M
Amortization of Deferred Charges 0.03M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M0.11M
Depreciation & Amortization (CF) 0.31M1.17M0.23M0.22M0.18M0.26M0.17M0.16M0.14M0.17M0.10M0.09M0.06M0.06M0.05M0.04M0.04M0.04M0.04M0.05M0.04M0.04M
Change in Working Capital
Change in Receivables 5.03M4.66M-4.17M-10.10M-4.33M-5.80M0.02M-0.77M-1.32M0.79M-0.24M3.77M-5.73M-0.25M1.17M-2.38M2.34M6.25M-3.90M-1.30M3.20M-1.25M
Change in Inventory -0.01M0.53M0.10M-1.31M1.61M
Change in Account Payables 3.85M1.05M3.40M5.21M3.97M1.09M
Change in Accured Expenses 5.15M7.52M-6.32M-1.71M-1.72M-0.98M-2.79M0.22M-1.20M5.85M-7.11M0.04M2.15M2.88M-2.25M2.17M1.04M1.21M1.21M-2.79M1.07M1.23M
Other Working Capital Changes -0.62M-0.62M-0.62M-0.12M-0.25M-0.55M-7.68M1.38M-3.06M-0.21M0.68M-1.13M-0.29M-0.36M-0.89M0.31M-0.30M5.31M-1.85M7.67M-4.22M-0.40M
Investing Activities
Capital Expenditures 0.07M0.01M0.03M0.02M0.00M0.00M0.07M0.04M0.01M-0.00M0.00M0.01M0.03M0.07M0.56M0.37M0.14M4.05M
Change in Acquisitions & Divestments 26.94M13.95M12.28M13.91M24.64M6.04M15.61M10.21M9.70M5.32M2.38M4.44M7.03M6.49M8.35M12.55M8.10M5.00M2.48M22.40M10.99M6.54M
Cash from Investing Activities 6.26M8.12M7.76M-10.09M16.34M-2.69M11.54M-1.98M11.68M3.65M2.07M2.53M-5.81M-2.26M-1.02M9.27M4.87M-53.09M-3.95M7.07M-18.14M-2.99M
Financing Activities
Other financing activities 0.02M-3.57M-2.47M16.11M2.51M0.27M0.51M1.89M-1.53M-1.17M
Cash from Financing Activities 0.12M0.14M24.29M-0.77M-0.44M0.68M11.93M2.58M2.14M0.32M3.04M5.33M20.01M1.89M2.40M105.77M3.37M0.36M1.50M3.24M0.65M0.09M
Additional items
Change in Cash -2.85M2.45M17.72M-14.33M5.43M-6.00M11.22M-5.74M2.04M-3.07M-6.09M4.96M6.28M-4.89M-7.58M107.94M-0.36M-66.62M-6.17M28.41M-30.15M-17.73M
Beginning Cash Balance 14.02M11.17M13.62M31.34M17.01M22.44M16.44M5.74M21.92M23.96M20.89M14.80M19.77M26.05M21.16M13.58M121.52M121.16M54.54M48.37M76.78M17.73M
Free Cash Flow -9.29M-5.83M-14.36M-3.49M-10.47M-3.98M-12.32M-6.38M-11.78M-7.03M-11.20M-2.90M-7.92M-4.52M-8.97M-7.10M-8.63M-13.96M-4.29M17.73M-12.80M-18.87M
Net Cash Flow -2.85M2.45M17.72M-14.33M5.43M-6.00M11.22M-5.74M2.04M-3.07M-6.09M4.96M6.28M-4.89M-7.58M107.94M-0.36M-66.62M-6.17M28.41M-30.15M-17.73M